Dark

INTS
Intensity Therapeutics, Inc. Common stock
stock NASDAQ

At Close

Feb 13, 2026 3:59:30 PM EST

0.2504USD-32.525%(-0.1207)9,333,723

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Feb 13, 2026 9:28:30 AM EST

0.2716USD-26.812%(-0.0995)1,170,615

After-hours

Feb 13, 2026 4:57:30 PM EST

0.2500USD-0.160%(-0.0004)68,697

Overview HistoricalExchangesShortsMore

open chart

Market Cap

15.04M

Industry

Biotechnology

Next Earnings

Mar 12, 2026 (24d)

INTS Stats

Avg. Vol. 10 Day

1,611,898

Avg. Vol. 30 Day

1,330,469

Market Cap

15,043,270

Shares Out.

60,064,965

On/Off Exchange

30%/70%

6 Month Beta

-5.22

1 Year Beta

-1.12

2 Year Beta

-0.61

3 Year Beta

-0.40

52 Week Low

0.19

52 Week High

2.50

SMA50

0.41

SMA200

0.37

1 Week

-35.77%

1 Month

-40.10%

3 Month

-42.82%

6 Month

-15.02%

1 Year

-88.13%

2 Year

-91.73%

Profile

intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company's technology and products.

INTS Stock Summary

Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) stock price today is $0.2504, and today's volume is 9,333,723. INTS is down -32.525% today. The 30 day average volume is 1,330,469. INTS market cap is 15.04M with 60,064,965 shares outstanding.

.dark-mode .v83RRd{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .v83RRd{ color: #333333; background-color: white; border: 2px solid #333333; }INTSIntensity Therapeutics, Inc. Common stockstock NASDAQ

INTS Stock Summary

INTS
Intensity Therapeutics, Inc. Common stock
stock NASDAQ